News EN

October is Liver Cancer Awareness Month:

By Carina Bobzin / October 12, 2021 /
Liver Cancer Awareness Month

Liver cancer remains the third most frequent cause of cancer-related death globally.Prevention, early detection and access to care are therefore extremely important for the improvement of patient outcomes.The global White Paper adresses these strategies, which can be found on www.swisshepa.org

weiter lesen...

international pbc day 2021

By Carina Bobzin / September 7, 2021 /
international pbc day 2021

Sunday 12 September

weiter lesen...

Haemochromatosis (iron overload): Interview width Dr. med. Nadine Stanek

By Carina Bobzin / June 29, 2021 /
Haemochromatosis (iron overload): Interview width Dr. med. Nadine Stanek

“What is haemochromatosis?” In this interview, Dr Stanek explains to us this genetically caused iron overload, which can also massively attack the liver. She informs us about the correlations and the interaction as a result of an increased iron concentration in the blood and the good therapy options with early recognition. Genetic tests in the…

weiter lesen...

Haemochromatosis (iron overload): Presentation by Dr. med. Nadine Stanek

By Carina Bobzin / June 29, 2021 /
Haemochromatosis (iron overload): Presentation by Dr. med. Nadine Stanek

“What is haemochromatosis?” In her presentation, Dr. Stanek describes in detail the genetic predisposition and the interaction of genes in iron overload disease. She shows us what a disturbed iron regulation in the liver can cause. From diagnosis, to symptoms, to risk factors, Dr. Stanek leads us to the various helpful forms of therapy. Genetic…

weiter lesen...

Liver cirrhosis: Interview with Prof. Dr. med. Annalisa Berzigotti

By Carina Bobzin / June 7, 2021 /
Cirrhosis Interview Specialist

“A patient should not feel alone!” Prof. Berzigotti explains what liver cirrhosis is, which can be the consequence of chronic liver inflammation. This process can often be slowed down, improved or even stopped by early detection or a healthier lifestyle of the patient. She also draws our attention to the importance of good cooperation and…

weiter lesen...

Liver cirrhosis: Presentation by Prof. Dr. med. Annalisa Berzigotti

By Carina Bobzin / June 7, 2021 /
Liver cirrhosis: Presentation by Prof. Dr. med. Annalisa Berzigotti

“How can liver cirrhosis develop?” Prof. Berzigotti describes liver cirrhosis, which can develop through various chronic liver damages caused by factors such as alcohol, HCV, HBV, NASH/MAFLD, autoimmunity and iron. She vividly presents the slow path that can lead to cirrhosis and the treatment options that exist. She also explains the great opportunity of how…

weiter lesen...

Alcohol and the liver: Interview with Dr. med. Susana Gomes Rodrigues

By Carina Bobzin / May 28, 2021 /
Alcohol and the liver: Interview with Dr. med. Susana Gomes Rodrigues

With her sympathetic nature, Dr. Rodrigues informs about the “taboo subject” – alcohol and the liver -. In an uncomplicated way, she shows us coherences, risks and treatment options. It is important to her that there is a healthy basis of trust between the doctor and patient, because this is how the greatest treatment successes…

weiter lesen...

Alcohol and the liver: Presentation by Dr. med. Susana Gomes Rodrigues

By Carina Bobzin / May 28, 2021 /
Alcohol and the liver: Presentation by Dr. med. Susana Gomes Rodrigues

Alcohol and the liver – a stigma in our society – and yet we are all confronted with it in our everyday lives. Dr. Rodrigues takes us step by step in her patient-friendly, scientifically sound educational process. She also shows us that we can help decisively through personal responsibility. Together we are strong! More about…

weiter lesen...

Primary sclerosing cholangitis (PSC): Interview with Prof. Dr. med. Stephan Vavricka

By Carina Bobzin / May 21, 2021 /
Primary sclerosing cholangitis (PSC): Interview with Prof. Dr. med. Stephan Vavricka

“What is primary sclerosing cholangitis?” Prof. Vavricka addresses in this interview PSC, one of the rare so-called autoimmune liver diseases. Bile duct cancer can occur as an additional complication of PSC. He explains that in 60% to 80% of cases, PSC is accompanied by inflammatory bowel disease (examples: Crohn’s disease, ulcerative colitis). More information about…

weiter lesen...

Primary sclerosing cholangitis (PSC): Presentation by Prof. Dr. med. Stephan Vavricka

By Carina Bobzin / May 21, 2021 /
Primary sclerosing cholangitis (PSC): Presentation by Prof. Dr. med. Stephan Vavricka

“What does primary sclerosing cholangitis mean?” PSC is probably caused by the patient’s own immune system, explains Prof. Vavricka. In this rare liver disease, the bile ducts first become inflamed before a bile stasis occurs. The bile stasis can lead to cirrhosis as the liver becomes scarred. More information about the liver disease Primary sclerosing…

weiter lesen...